Lisa C. Costello-Boerrigter
Cardiorenal Research Laboratory
Division of Cardiovascular Diseases
Mayo Clinic
Rochester
USA
Name/email consistency: high
- The effect of the brain-type natriuretic peptide single-nucleotide polymorphism rs198389 on test characteristics of common assays. Costello-Boerrigter, L.C., Boerrigter, G., Ameenuddin, S., Mahoney, D.W., Slusser, J.P., Heublein, D.M., Redfield, M.M., Rodeheffer, R.J., Olson, T.M., Burnett, J.C. Mayo Clin. Proc. (2011)
- Renal and anti-aldosterone actions of vasopressin-2 receptor antagonism and B-type natriuretic peptide in experimental heart failure. Costello-Boerrigter, L.C., Boerrigter, G., Cataliotti, A., Harty, G.J., Burnett, J.C. Circ. Heart. Fail (2010)
- Pharmacology of vasopressin antagonists. Costello-Boerrigter, L.C., Boerrigter, G., Burnett, J.C. Heart. Fail. Rev (2009)
- Mineralocorticoid escape by the kidney but not the heart in experimental asymptomatic left ventricular dysfunction. Costello-Boerrigter, L.C., Boerrigter, G., Harty, G.J., Cataliotti, A., Redfield, M.M., Burnett, J.C. Hypertension (2007)
- V2 receptor antagonism with tolvaptan in heart failure. Costello-Boerrigter, L.C., Boerrigter, G., Burnett, J.C. Expert. Opin. Investig. Drugs (2007)
- Amino-terminal pro-B-type natriuretic peptide and B-type natriuretic peptide in the general community: determinants and detection of left ventricular dysfunction. Costello-Boerrigter, L.C., Boerrigter, G., Redfield, M.M., Rodeheffer, R.J., Urban, L.H., Mahoney, D.W., Jacobsen, S.J., Heublein, D.M., Burnett, J.C. J. Am. Coll. Cardiol. (2006)
- Vasopressin-2-receptor antagonism augments water excretion without changes in renal hemodynamics or sodium and potassium excretion in human heart failure. Costello-Boerrigter, L.C., Smith, W.B., Boerrigter, G., Ouyang, J., Zimmer, C.A., Orlandi, C., Burnett, J.C. Am. J. Physiol. Renal Physiol. (2006)
- The prognostic value of N-terminal proB-type natriuretic peptide. Costello-Boerrigter, L.C., Burnett, J.C. Nature Clinical Practice. Cardiovascular Medicine (2005)